Harvard’s R&D alliance with Resilience to advance manufacture of complex medicines – Harvard Gazette
Research Roundup: T-Cell Immune Response to COVID-19 Vaccines and More – BioSpace
Harvard University and National Resilience, Inc. (Resilience), a manufacturing and technology company, have established a five-year R&D alliance with a $30 million commitment from Resilience directed toward the development of complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. Under the alliance agreement coordinated by Harvards Office of Technology Development (OTD), Resilience will fund faculty-initiated research focused on certain novel therapeutic and biomanufacturing technologies pioneered in University labs.
The Junk Overlooked DNA Might Solve The Mystery Of Unique Human Brain – BioTecNika
Every week there are numerous scientific studies published. Heres a look at some of the more interesting ones.
Facts About Abortion: Stem Cell Research and Abortion
What Makes Human Brain Unique? Around 98% of the DNA sequences in the Homo sapiens genome are non-coding regions that were previously dismissed as junk DNA. Actually, junk DNA contains a number of regulatory regions that particularly regulate gene expression
ASU professor researches origins of Alzheimers to find a cure – Eight, Arizona PBS
> Page Summary: Embryonic stem research cannot take place apart from dead human embryos. Embryonic stem cells cannot be culled without killing the embryo.
Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why Its So Aggressive – On Cancer – Memorial Sloan Kettering
ASU Associate Professor Dr. David Brafman is using personalized medicine to study the origins of Alzheimers. Dr.
Taking aim at the brain, Takeda strikes up cell therapy R&D alliance with Immusoft – MedCity News
Imagine youre about to go on a cross-country trip, stopping at spots along the way to admire local attractions. Youd probably want to have a road atlas handy, containing maps at different scales, covering both the major highways and the roads of smaller cities and towns or at least a GPS that can access a digital atlas with this information. Until recently, cancer researchers have been like cross-country travelers with only a few maps of a few popular cities.
Longevity Foundation to Fund Geroscience Research with 860M – Labiotech.eu
The first cell therapies made from a patients own cells were cancer treatments T cells engineered to hit tumors. Immusoft is taking a similar approach with a different type of immune cell, aiming to deliver these cell therapies into the brain. The biotech startup is still preclinical, but Takeda Pharmaceutical sees enough promise to begin a research and development alliance that could yield new treatments for rare neurometabolic diseases.
Advances in Assisted Reproduction: What Can We Expect? – BioNews
The newly-created Longevity Science Foundation aims to extend the human lifespan to more than 120 years by channeling over 860M ($1B) into early-stage geroscience research in the next decade. Experts say thats a worthy if complex goal. Based in Zug, Switzerland, the Longevity Science Foundation will prioritize four areas of research: personalized medicine, therapeutics, artificial intelligence (AI) and predictive diagnostics.
The complex dynamics of stem cell tethers and slings – EurekAlert
11 October 2021 Digital Media and Content Specialist, International Livestock Research Institute The UK Government recently announced its intention to extend the maximum storage limit, for frozen eggs, sperm and embryos, to 55 years across the board (see BioNews 1111).
image:Research conducted at KAUST aims to improve how stem cells move in the body so that they can reach where they are needed following transplantation. view more Credit: 2021 KAUST; Anastasia Serin.